Back

Importance of atrial cardiomyopathy in patients with embolic stroke of unknown cause and its prognostic significance

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and the brain Mechanisms for Stroke EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Michael Gotzmann

Catholic Clinic Bochum - Ruhr University hospital, Bochum (Germany)

6 More presentations in this session

Presentation thumbnail
Phenotypic clustering of patients with atrial fibrillation at high risk of bleeding and stroke: insights from three global registries
Doctor A. Askarinejad (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Prolonged ECG monitoring after transient ischaemic attack for atrial fibrillation detection: feasibility of using meta-machine learning algorithm
Doctor J. Tan (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Statin therapy and synergistic effect of ezetimibe for the prevention of stroke with atrial fibrillation populations: nationwide cohort study
Mr C. Kim (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
Cognitive function and working memory assessment using the REMEDES system in patients with atrial fibrillation
Doctor K. Triantafyllou (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Quality of life after atrial fibrillation ablation: a comparison of pulsed-field versus radiofrequency energy
Doctor C. Isenegger (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and the brain

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Anticoagulation after embolic stroke of undetermined source - therapeutic dilemmas.
thumbnail
Congress Presentation
Atrial cardiomyopathy in the electrocardiogram: the prognostic value of p-wave abnormalities in a primary care population
thumbnail
Congress Session
Echocardiographic imaging in atrial fibrillation and atrial cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources